Tango Therapeutics, Inc.
TNGX
DELAYED 1 MONTH
9 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 3 10:37 PM | Adam CrystalPresident, R&D | Sale | 27,000 | $22.87 | $617.6K | 115,743(D) | View → |
| May 1, 2026 | May 5 11:47 PM | Adam CrystalPresident, R&D | Sale | 27,000 | $21.23 | $573.1K | 115,743(D) | View → |
| Mar 5, 2026 | Mar 9 8:01 PM | Adam CrystalPresident, R&D | Sale | 20,251 | $15.00 | $303.8K | 112,622(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 8 10:08 PM | John B KetchumDirector | Grant/Award | 25,000 | $20.22 | 25,000(D) | View → |
| Jun 5, 2026 | Jun 8 10:01 PM | Lesley Ann CalhounDirector | Grant/Award | 25,000 | $20.22 | 25,000(D) | View → |
| Jun 5, 2026 | Jun 8 9:55 PM | Mace RothenbergDirector | Grant/Award | 25,000 | $20.22 | 25,000(D) | View → |
| Jun 5, 2026 | Jun 8 9:49 PM | Sung LeeDirector | Grant/Award | 3,570 | $20.22 | 3,570(D) | View → |
| Jun 1, 2026 | Jun 3 10:37 PM | Adam CrystalPresident, R&D | Option Exercise | 27,000 | $5.20 | 341,040(D) | View → |
| May 1, 2026 | May 5 11:47 PM | Adam CrystalPresident, R&D | Option Exercise | 27,000 | $5.20 | 368,040(D) | View → |
| May 1, 2026 | May 5 11:46 PM | Matthew GallChief Financial Officer | Grant/Award | 240,000 | $20.98 | 240,000(D) | View → |
| Apr 29, 2026 | May 1 9:26 PM | Sung LeeDirector | Grant/Award | 5,200 | $22.06 | 5,200(D) | View → |